REFERENCES
- Kang Bo Ki, et al. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. International Journal of Pharmaceutics 2004; 274: 65–73
- Chen B. P., Chow M. S. S. Focus on carvedilol: A novel Beta-adrenergic blocking agent for the treatment of congestive heart failure. Formulary 1997; 32: 795–805
- Cui Shenmiao, et al. Self-microemulsifying drug delivery system (smedds) for improving in vitro dissolution and oral absorption of pueraria lobata isoflavone. Drug Development and Industrial Pharmacy 2005; 31: 349–356
- Hauss David J., et al. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. Journal of Pharmaceutical Science 1998; 37: 164–169
- Lu En-Xian, Jiang Zhi-Qiang. A water-insoluble drug monolithic osmotic tablet system utilizing gum arabic as an osmotic, suspending and expanding agent. Journal of Controlled Release 2003; 92: 375–382
- Theeuwes F. Elementary osmotic pump. Journal of Pharmaceutical Science 1975; 64: 1987–1991
- Fischer G., BarShalom D. Controlled Release Solid Dispersions Containing Carvedilol. WO Patent 24,426, 2003
- Gershanik T., Haltner E. Charge-dependent interaction of self-emulsifying oil formulations with Caco-2 cells monolayers: binding, effects on barrier function and cytotoxicity. International Journal of Pharmaceutics 2000; 211: 29–36
- John G. Lyons, Hallinan Mark. Preparation of monolithic matrices for oral drug delivery using a supercritical fluid assisted hot melt extrusion process. International Journal of Pharmaceutics 2007; 319(1–2)62–71
- Kim H. J., Yoon K. A. Preparation and in vitro evaluation of self-microemulsifying drug delivery systeme containing idebene. Drug Development and Industrial Pharmacy 2000; 26(5)523–529
- Kusumoto K., Hoshino T. Sustained-Release Medicines Containing Angiotension 5Antagonists. WO Patent 13,609, 2003
- Wei Lanlan, Sun Peinan. Preparation and evaluation of SEDDS and SMEDDS containing carvedilol. Drug Development and Industrial Pharmacy 2005; 31: 775–784
- Ruusunen Marita, Puolanne Eero. Reducing sodium intake from meat products. Meat Science 2005; 70: 531–541
- Morgan T. Clinical pharmacokinetics and pharmacodynamics of carvedilol. Clinical Pharmacokinetics 1994; 26(5)335–346
- Oh C. K. Nover Oral Dosage Form for Carvedilol. WO Patent 24,017, 1999
- Oh C. K. Carvedilol Formulations Containing Cyclodextrin. WO Patent 28,718, 2003a
- Oh C. K. Oral Composition of Carvedilol. WO Patent 28,649, 2003b
- Porubcan L. S., Serna C. J., White J. L., Hem S. L. Mechanism of adsorption of clindamycin and tetracycline by montmorillonite. Journal of Pharmaceutical Science 1978; 67: 1081–1087
- Defang Ouyang, Shufang Nie, Weisan Pan. In vitro and in vivo evaluation of two extended release preparations of combination metformin and glipizide. Drug Development and Industrial Pharmacy 2005; 31: 677–685
- Robert O., William III. Characterization of an inclusion complex of cholesterol and hydroxypropyl-β cyclodextrin. European Journal of Pharmaceutics and Biopharmaceutics 1998; 46: 355–360
- Tantishaiyakul V. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone. International Journal of Pharmaceutics 1999; 181: 143–151
- Gershanik Tatyana. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. European Journal of Pharmaceutics and Biopharmaceutics 2000; 50: 179–188
- Li Xiaodong, et al. Studies on controlled release effervescent osmotic pump tablets from traditional chinese medicine compound recipe. Journal of Controlled Release 2004; 96: 359–367
- Gan Yong, Pan Weisan. Cyclodextrin complex osmotic tablet for glipizide delivery. Drug Development and Industrial Pharmacy 2002; 28(8)1015–1021